We tested this possibility further by staining tumor sections with antibodies to E-cadherin (Cdh1), Vimentin (Vim) and pan-Cytokeratins (pan-Ck) to assess EMT as a function of host platelet miRNAs. The gene discussed is CDH1; the disease is neoplasm.